Member Info for MrRipley

Right but 6 months ago the talk was they won’t achieve what they did in mice and it had all gone wrong hence the silence. Then it’s revealed they’re getting the protocol changed to go further. Now it was a given?

How is my post on launch misleading? The max dilution from here is 10%, many companies did fail to raise funding, some did go bust, and here we are funded til 2024/25 as per the prelims a week ago…. So which point is misleading?

Right so when each DE is complete and data emerges that will be boring will it?

right, so when avacta said just a week or so ago they are funded til the end of 2024/start of 2025, what did you take that to mean? and what part is *******s?

how would you have raised funds and what part is *******s?

How is Avacta being unable to find a maximum tolerated dose being spun into a negative? So one of the deadliest forms of chemo, Doxorubicin, being very well tolerated to the point the DEs go on is somehow worse than us finding MTD at DE3 or 4? Or put simply, it’s working so well that we’ve made a deadly chemo not deadly…. And that’s bad how?

It’s idiots night out on here I see.

We’ve been told it is progressing better than expected and they didn’t expect to reach this cohort or dose….. not really that hard to follow.

Hahahahahaha you mean like taking the SP from 14p to where it is now, taking Avacta into clinic, moving it on from Covid unlike any other company, and proving pre|CISIONS method of action works at many times the standard dose? This P1a delay is caused by AVA6k working better than expected, so we’ll they had to re write the protocol. We’re funded into 2024/25, they raised funds in the middle of a financial crisis, when many other cos couldn’t and some went bust. The focus is entirely on heights right now and absolutely not on how well Precision, inc 3996 is performing because that’s the current agenda.

They’ve not been paid in cash once. There’s a further max dilution of 10% taking us to 300m shares in issue. That’s if Avacta continue to pay in shares. So for arguments sake someone’s 10k shares are diluted by 10% max over 5 years. Or 2% a year. Are you saying that that’s enough to put people off buying when the potential SP in that timeframe could massively take off? Or is it a case that heights are funding Avacta since that’s what they’re in it for, otherwise a capital raise would have been used instead and they’d be the largest of all holders, and they’re simply taking their profit at circa 20% average? It’s baffling to call 2% per annum the kind of dilution that would worry most, and suggest that paying in shares adds to cash burn. It’s simply wrong.

What’s that got to do with cash burn???? Absolutely nothing.

You’ve ignored it again. Why are you classing heights payments as cash burn when it’s paid in shares?

It’s not going out though is it. It’s being issued as shares. So it adds…….. nothing to cash burn. Nothing. They haven’t paid a single penny back in cash so there is no excess cash burn. So what you’re talking, on top of your 30% Gaff, it’s complete crap.

How come you haven’t acknowledged your 30% over 5 years gaff?

Ohhh so cash isn’t an issue, but it is an issue. Yeah…. But…. No…. But yeah…. But no.

So cash until the end of next year, start of 2025, with masses of news before then and you think cash is an issue right now? Ok pal………………

There’s 2/3 cohorts and P1a to come to an end plus whatever else comes out the blue, inc data. So any talk of waiting for STS data as the next inflection point is absolute tripe.

Except he didn’t.

Morons must be early on the four x today.

We’ve got funding til the end of next year you thick twat.

I think this cohort will last 6 weeks. So next week is quite likely IMO.

No it isn’t. There isn’t £3m or so every 3 months in interest is there.